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INTRODUCTION
Idiopathic ulcerative colitis (IUC), beside 
Crohn’s disease, represents the most frequent 
clinical entity among chronic inflammatory 
bowel diseases [1, 2, 3]. It is characterized by 
diffuse mucosal inflammation most prominent 
in the distal parts of the colon, and in a smaller 
number of cases also in the region of the termi-
nal ileum (“backwash ileitis“) [2, 4]. However, 
the increased usage of gastroscopy at the time of 
initial colonoscopy was followed by the under-
standing that histological lesions can be also 
seen on the gastric mucosa [5]. Depending on 
the extent of the inflammation of the colon, 
IUC is classified as proctitis, proctosigmoiditis, 
left-sided colitis and pancolitis [1, 2, 3]. In chil-
dren the pancolitic form is most frequent, occa-
sionally occurring under the feature of “toxic 
colon“ [3]. In addition, in a significant number 
of cases the disease is also followed by hepato-
biliary and systemic manifestations [1, 2, 3].
According to the results of different regional 
studies, today 41.1-150:100,000 persons suffer 
from IUC, while the annual incidence ranges 
from 1.4-7.3:100,000 persons [1, 3]. Although 
the data for children are considerably fewer, 
it is estimated that both the prevalence and 
the annual incidence are almost identical to 
those in adults [1]. Also, it is known that the 
white race has a higher predisposition for the 
disease, particularly Ashkenazi Jews, as well as 
the population living in the developed coun-
tries, urban areas and regions with cold climate 
[6-9]. The difference in gender predisposition 
for the disease has not been proved [8, 9].
Although being recognized as a clinical entity 
135 years ago, the pathogenesis of IUC has not 
been fully clarified until today [1, 2, 10]. It is 
considered that beside polygenic predisposition 
different environmental factors also play the 
basic role in the development of the disease [2, 
6, 9-12]. The autoimmune hypothesis, based on 
the activation of macrophages in the large bowel 
mucosa by still unidentified antigens, is consid-
ered as most acceptable [2, 10]. According to 
this hypothesis the activated macrophages 
secrete proinflammatory cytokines which, by 
binding to the cell receptors of the immune 
system, lead to different autocrine and paracrine 
effects resulting in an uncontrolled inflamma-
tory process, i.e. bowel mucosa damage, as well 
as other manifestations of the disease. The most 
significant proinflammatory cytokines are inter-
leukin-1 and -6, tumour necrosis factor alpha 
and chemokine IL-8 [10].
SUMMARY
Introduction Idiopathic ulcerative colitis (IUC) represents a rare disease of childhood. It usually occurs 
at age over 10 years, and below that exceptionally rarely.
Objective The aim of the paper was to analyze the clinical signs, symptoms and therapeutic proce-
dures in children with IUC.
Methods The aims of the paper were based on a sample of 17 children (11 male and 6 female, mean 
age 11.90±3.50 years; range 3.8-17.5 years) with IUC. The disease diagnosis was based on characteristic 
endoscopic and pathohistological findings.
Results The basic signs of the disease involved chronic mucosal haemorrhagic diarrhoea which was 
confirmed in 16 of 17 patients, with body weight deficiency (10), recurrent abdominal pain (6), fever (5), 
slowed-down maturation (5), marked anorexia (4), and tenesmus (3). Two patients had recurrent aphthous 
stomatitis, 2 anal fissures, 2 arthralgia, one autoimmune hepatitis and one pyoderma gangrenosum. None 
of the children had longitudinal growth retardation. Elevated sedimentation rate and C-reactive protein 
in blood were registered in 11, sideropenia in 10, anaemia in 6 and hypoalbuminemia in 3 patients. The 
remission of proctosigmoiditis and left-sided colitis was achieved with aminosalicylates, and of panco-
litis with the combination of aminosalicylates and glucocorticoids, except in cases of steroid-depen-
dent colitis, which additionally required azathioprine.
Conclusion The main signs of IUC in children are chronic mucous haemorrhagic diarrhoea, body weight 
loss and sideropenic anaemia, while the basic therapy consists of aminosalicylates, and in more severe 
cases of the disease the initial use of glucocorticoids and later azathioprine.
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OBJECTIVE
The study aim was to analyze symptoms, clinical and labo-
ratory findings in children with IUC. In addition, thera-
peutic procedures, by which a complete clinical and labo-
ratory disease remission was achieved, were also taken 
into consideration.
METHODS
The study goals were achieved on a sample of 17 children, 
11 male and 6 female, aged 3.8 to 17.5 years (11.90±3.50 
years), hospitalized due to IUC and treated from 2000 to 
2007. Beside taking a detailed medical history involving 
the onset, type, character of the problems, and a complete 
clinical examination, including a precise measurement of 
body height (BH) and body weight (BW) compared to 
standard values, each patient also underwent correspond-
ing laboratory analyses: erythrocyte sedimentation rate, 
C-reactive protein, a complete blood count with leuko cyte 
formula, serum iron, total protein and albumin concen-
tration in blood, ionogram, blood acid-base, hepatogram, 
prothrombin time, partial thromboplastin time, as well 
as three consecutive examinations of stool for pathogenic 
bacteria and Entamoeba histolytica [13]. In addition to 
the clinical examination, to define precisely the degree of 
the patient’s maturation, X-ray en-face images of the left 
hand were compared to the corresponding standard. After 
the required preparation, all patients underwent a video-
gastroduodenoscopy and a total colonoscopy with multi-
ple biopsies of the gastric mucosa, duodenum and colon. 
The obtained endoscopic findings, as well as biopsy loca-
tions were recorded in detail. Immediately after collection, 
the samples of gastric mucosa, duodenum and colon were 
immersed in a 4% puferized formalin solution and sent for 
a pathological analysis. IUC diagnosis was based on char-
acteristic endoscopic and pathohistological findings. The 
exclusion of amebiasis and bacterial infections was of addi-
tional diagnostic and therapeutic significance.
The undertaken therapeutic measures that depended 
on the severity of the disease and achieved effect were 
recorded and analyzed in detail.
The frequency of symptoms, clinical signs and labora-
tory findings of IUC, as well as the effect of therapeutic 
procedures are presented in absolute numbers, while non-
compliant BW related to the ideal for the corresponding 
age, gender and height is expressed in percentages.
RESULTS
Mean time from the onset of the disease symptoms to 
IUC diagnosis in our patients was 4.67±8.65 months. 
The predominant clinical sign of the disease was chronic 
mucosal haemorrhagic diarrhoea revealed in 16 of 17 
patients, BW deficiency, recurrent abdominal pain, fever 
and anorexia (Table 1). Five patients had BW deficiency of 
over 20% compared to age- and gender-related standards, 
while BH was normal in all. Skeletal maturity retardation 
(range -0.33 to -2.33 years, mean value -0.75±0.79 years) 
was recorded in five patients; three with pancolitis and two 
with left-sided colitis. Two patients had aphthous stoma-
titis, 2 anal fissures and arthralgia, 2 aphthous stomati-
tis, one pyoderma gangrenosum and another one auto-
immune hepatitis. The most frequent laboratory abnor-
malities were elevated sedimentation rate and increased 
C-reactive protein in blood recorded in 11 patients, sidero-
penia, anaemia and hypoalbuminemia (Table 2).
Of 17 patients, eight had left-sided colitis, six pancolitis 
and three proctosigmoiditis. None of the patients had either 
extraintestinal manifestations or microscopic changes of 
the gastric mucosa. The frequency of the extraintestinal 
manifestations and their association with the extent of 
bowel mucosa inflammation is presented on Table 3.
In children with rectosigmoiditis and left-sided colitis 
disease remission was achieved by application of amino-
salicylates (40-60 mg/kg/day), and in pancolitis patients 
by aminosalicylates combined with prednisone (1-2 mg/
kg/day, maximally 40 mg/mg/kg/day) for 14 days. Fifteen 
patients were kept in remission by aminosalicylates (30-50 
mg/kg/day), and two with steroid-dependent pancolitis by 
aminosalicylates combined with azathioprine (1.5-2 mg/
kg/day). The therapeutic measures were not followed by 
any side-effects. None of the patients required specific diet 
or blood transfusion. Having in mind the probiotic char-
acteristics of yoghurt, this dairy product was suggested to 
Table 1. Symptoms and clinical signs of idiopathic ulcerative colitis in 
17 patients
Symptoms/clinical signs Number of 
patients
Chronic mucosal haemorrhagic diarrhoea 16
Body weigh deficiency more than 10% 10
Recurrent abdominal pain 6
Fever 5
Anorexia 4
Tenesmus 3
Table 3. Frequency of idiopathic ulcerative colitis extraintestinal ma-
nifestations dependent of the extent of bowel mucosa inflammation
Manifestation Pancolitis Left-sided 
colitis
Body weight deficiency 5 5
Slowed-down maturation 3 2
Fever 4 1
Arthralgia 2 0
Pyoderma gangrenosum 1 0
Table 2. Basic laboratory findings in 17 patients
Laboratory parameters Number of 
patients
Range 
(X±SD)
Elevated sedimentation rate 11 27–110 
(41.67±33.51)
C-reactive protein >5 mg/l 11 6–103 
(29.93±32.37)
Serum iron <10.7 μmol/l 10 2.7–9.9
(6.78±4.58)
Anaemia (Hb<115 g/l) 6 60–109 
(92.16±18.06)
Albumin level in blood <37 g/l 3 26–28
(27.00±1.00)
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all. Iron deficiency recorded in 10 patients was corrected 
orally over a 2-4 month period. Also, the intake of multi-
vitamin preparations during the first 2-3 months of recov-
ery was suggested to all the patients.
DISCUSSION
At the time of diagnosis, the age of our patients was about 12 
years, same as reported by other authors [7, 8, 10]. Some of 
them have indicated that the average age of the disease onset 
can be even considerably lower, which may be explained by 
a more expressed predisposition and/or higher influence 
of external factors, as well as by a better paediatric health-
care [20]. In our sample of patients the number of boys 
compared to those of girls was higher but without signifi-
cance, as detected by other authors [7, 18, 19].
In our patients the average time elapsed from the onset 
of first symptoms to IUC diagnosis was rather long (about 
4.5 months), but without any significant difference in 
comparison to other authors [7, 18, 19, 20]. Having in mind 
the fact that IUC is rare in children, the main reason for this 
occurrence is parents’ and/or the physician’s belief that the 
child is affected by infective disease which feature similar 
clinical presentation, such as amebiasis or relapsing bacte-
rial diarrhoea. Initially, in several patients the disease had 
a mild course or their clinical symptoms predominantly 
consisted of extraintestinal manifestations. Two children 
were the victims of inadequate care; in one due to a prema-
ture death of both parents and in another due to parent’s 
low educational level.
The basic clinical signs of IUC in children are muco-
sal haemorrhagic diarrhoea, followed by abdominal pains, 
fever, anorexia, BW deficiency and tenesmus, which was 
also revealed in our group of patients [1, 2, 3, 7, 14, 21]. 
Other disease manifestations, such as aphthous stomatitis, 
anal fissures, autoimmune stomatitis, fever, retardation of 
longitudinal growth and maturity, arthralgia or arthritis, 
pyoderma gangrenosum and other were considerably rarer 
or rare [15-22]. In our group of patients fever and slowed-
down maturation were recorded in less than one-third, 
while aphthous stomatitis, anal fissures and arthralgia in 
4. Only one patient had pyoderma gangrenosum, another 
one autoimmune hepatitis, while a slowed-down longi-
tudinal growth was not disclosed in any of the patients.
Increased erythrocyte sedimentation rate and C-reactive 
protein in blood, iron deficiency and sideropenic anaemia 
represent the basic laboratory findings in IUC patients [1, 
2, 3, 6-10]. Increased erythrocyte sedimentation rate and 
C-reactive protein in blood, the non-specific indicators of 
inflammation, are in correlation with the severity of the 
disease and its extent. In IUC sideropenia and sideropenic 
anaemia are multifactorial disorders. In their pathogenesis, 
beside rectorrhagia and anorexia, the significant partici-
pant is a hepatic polypeptide hepcidin which, as a reac-
tant of acute phase of inflammation, blocks the intestinal 
iron absorption, as well as its mobilization from the depot 
[23-26]. In the most severe forms of the disease, hypoalbu-
minemia develops as a consequential occurrence of exuda-
tive enteropathy and negative protein caloric outcome [1, 2, 
3]. In our three patients with pancolitis and severe malnu-
trition serum albumin level was subnormal.
Left-sided colitis was recorded in half of our patients, 
pancolitis in one-third and rectosigmoiditis in three. In 
the initial phase of childhood IUC other authors also 
report similar findings [18, 19, 20]. Sharif et al. indicate at 
the possibility of focal gastritis, not only in children with 
Chron’s disease, but also in those with IUC [5]. In all our 
patients, concurrently with colonoscopy, we also performed 
esophagogastroduodenoscopy with multiple biopsies and 
pathohistological analyses of gastric and duodenal mucosa, 
and none showed pathological findings.
Aminosalicylates form the basic therapy of IUC, which, 
in the severe forms of the disease must be initially combined 
with glucocorticoids [1, 2, 3, 27]. In slightly lower dosages, 
these preparations are most often sufficient for sustaining 
disease remission, except in its resistant forms when they 
are combined with cytostatics or other immunosuppres-
sive medications [1, 2, 3, 28, 29, 30]. In our patients with 
rectosigmoiditis and left-sided colitis, the remission was 
achieved with aminosalicylates only, while in those with 
pancolitis glucocorticotherapy was also necessary. In 15/17 
of our patients aminosalicylates were sufficient for sustain-
ing remission, except for two cases of steroid-dependent 
colitis in whose therapy azathioprine was added.
CONCLUSION
The predominant signs of IUC in children are chronic 
mucosal haemorrhagic diarrhoea, loss of body weight and 
sideropenic anaemia, recurrent abdominal pain, slowed-
down maturation and anorexia. In the phase of disease 
diagnostics in almost half of the children we verified left-
sided colitis, in one-third pancolitis and in one-fifth pros-
tosigmoiditis. In children with rectosigmoiditis and left-
sided colitis disease remission was achieved with amino-
salicylates and in those with pancolitis by the combination 
of aminosalicylates and glucocorticoids. Sustained remis-
sion of the disease can be achieved with amilosalycilates, 
except in resistant cases when the application of azathio-
prine is also necessary.
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КРАТАК САДРЖАЈ
Увод Иди о пат ски ул це ро зни ко ли тис (ИУК) је рет ко обо ље-
ње у де тињ ству. Обич но се ја вља по сле де се те го ди не, а из-
у зет но  ра ни је.
Циљ ра  да Циљ ра  да је био да се ана  ли  зи  ра  ју симп  то  ми, 
кли нич ки  зна ци  и  по ступ ци  ле че ња  де це  обо ле ле  од  ИУК.
М е  т о  д е  р а  д а  И с  п и  т а  н о  ј е  17  д е  ц е  ( ј е  д а  н а  е с т  д е  ч а  к а  и  ш е с т  
д е  в о ј ч и  ц а)  у з  р а  с т а  3 , 8 -17, 5  г о  д и  н а  (11,9 0 ± 3 , 5 0  г о  д и  н а)  с а  И У К .  
Д и  ј а г  н о  з а  б о  л е  с т и  ј е  п о  с т а  в љ е  н а  н а  о с н о  в у  т и  п и ч  н о г  е н  д о -
с к о п  с к о г   и   п а  т о  х и  с т о  л о  ш к о г   н а  л а  з а .
Ре зул та ти  Основ ни  кли нич ки  зна ци  бо ле сти  би ли  су:  хро-
н и ч  н а   с л у  з а  в о - к р  в а  в а   д и  ј а  р е  ј а   (к о д   16   б о  л е  с н и  к а),   г у  б љ е -
њ е  н а  т е   л е   с н о ј  т е   ж и   н и  (10 ),  п о   н а   в љ а   н и  б о л  у  т р   б у   х у  (6),  п о -
в и  ш е  н а   т е  л е  с н а   т е м  п е  р а  т у  р а   (5 ),   у с п о  р е  н о   с а  з р е  в а  њ е   (5 ),  
упа  дљи  ва ано  рек  си  ја (4) и те  не  зам (3). Код по два бо  ле  сни-
к а   у т в р ђ е  н и   с у   р е  ц и  д и  в и  р а  ј у  ћ и   а ф  т о  з н и   с т о  м а  т и  т и с ,   а н а л -
не  фи су ре  и  ар трал ги ја,  а  код  по  јед ног  ауто и му ни  хе па ти-
тис и pyoder ma gan gre no sum. Ни јед но де те ни је за о ста ја ло у 
л о н  г и  т у д и  н а л  н о м  р а  с т у.  Уб р з а  н а  се  д и  м е н  т а  ц и  ј а  е р и  т р о  ц и  т а  
и по ви шен ни во C- р е  а к  т и в  н о г  п р о  т е  и  н а  у  к р  в и  з а  б е  л е  ж е  н и  
су  код  11  бо ле сни ка,  си де ро пе ни ја  је  утвр ђе на  код  10,  ане-
м и  ј а  к о д  ш е с т,  а  х и  п о  а л  б у  м и  н е  м и  ј а  к о д  т р и  д е  т е  т а .  Ре  м и  с и  ј а  
р е к  т о  с и г  м о  и  д и  т и  с а  и  л е  в о  с т р а  н о г  И У К  о с т в а  р и  в а  н а  ј е  а м и -
н о  с а  л и  ц и  л а  т и  м а ,  а  п а н  к о  л и  т и  с а  њ и  х о  в о м  к о м  б и  н а  ц и  ј о м  с а  
гл и  к о  к о р  т и  к о  и  д и  м а .  Ре  м и  с и  ј а  б о  л е  с т и  ј е  о д р  ж а  в а  н а  а м и  н о -
са ли ци ла ти ма,  осим  код  сте роид-за ви сног  ИУК,  где  је  би ла 
нео п ход на  и  при ме на  аза ти о при на.
За кљу чак Глав ни зна ци ИУК код де це су хро нич на слу за во-
к р  в а  в а   д и  ј а  р е  ј а ,   г у  б и  т а к   т е  л е  с н е   т е  ж и  н е   и   с и  д е  р о  п е  н и ј  с к а  
а н е  м и  ј а ,  д о к  о с н о  в у  л е  ч е  њ а  ч и  н и  п р и  м е  н а  а м и  н о  с а  л и  ц и  л а -
та,  у  те жим  об ли ци ма  бо ле сти  ини ци јал на  при ме на  гли ко-
кор ти ко и да,  а  ка сни је  аза ти при на.
Кључ не  ре чи:  иди о пат ски  ул це ро зни  ко ли тис;  кли нич ки 
зна ци;  де ца
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